Show simple item record

dc.contributor.authorBahari, LA
dc.contributor.authorJavadzadeh, Y
dc.contributor.authorJalali, MB
dc.contributor.authorJohari, P
dc.contributor.authorNokhodchi, A
dc.contributor.authorShokri, J
dc.date.accessioned2018-08-26T07:19:43Z
dc.date.available2018-08-26T07:19:43Z
dc.date.issued2017
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/45700
dc.description.abstractIn controlled porosity osmotic pumps (CPOP), usually finding a single solvent with a capability to dissolve both film former (hydrophobic) and pore former (hydrophilic) is extremely challenging. Therefore, the aim of the present investigation was to tackle the issue associated with controlled porosity osmotic pump (CPOP) system using nano-suspension coating method. In the present study 4-Amino pyridine was used as a highly water soluble drug. In this method, a hydrophilic pore former (sucrose or mannitol) in nano range was suspended in polymeric coating solution using ball-mill. The performance of the prepared formulations was assessed in terms of D-12h (cumulative release percent after 12 h), Dev(zero) (mean percent deviation of drug release from zero order kinetic), t(L) (lag time of the drug release) and RSQ(zero). The results revealed that gelling agent amount (HPMC E-15LV) in core and pore former concentration in SPM had crucial effect on SPM,integrity. All the optimised formulations showed a burst drug release due to fast dissolving nature of the pore formers. Results obtained from scanning electron microscopy demonstrated the formation of nanopores in the membrane where the drug release takes place via these nanopores. Nano suspension coating method can be introduced as novel method in formulation of CPOPs. (C) 2017 Elsevier B.V. All rights reserved.
dc.language.isoEnglish
dc.relation.ispartofCOLLOIDS AND SURFACES B-BIOINTERFACES
dc.subjectDrug delivery
dc.subjectControlled porosity osmotic pumps (CPOPs)
dc.subjectNano-suspension coating
dc.subjectDrug release
dc.titleNano-suspension coating as a technique to modulate the drug release from controlled porosity osmotic pumps for a soluble agent
dc.typeArticle
dc.citation.volume153
dc.citation.spage27
dc.citation.epage33
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.1016/j.colsurfb.2017.02.007


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record